Ophthalmic composition

Details Ophthalmic composition Ophthalmic composition

1998-08-27

1999-12-07

Harrison, Robert H.

Drug, bio-affecting and body treating compositions

Contact lens treatment

514974, A61K 908, A61K 9107, A61K 4718, A61K 4740

Patent

active

059984880

ABSTRACT:
In an ophthalmic solution comprising an antimicrobial preservative having a quaternary ammonium type cationic group, there are blended a cyclodextrin, EDTA or its salt, and boric acid and/or borax. The solution has an excellent antimicrobial activity and is effective for inhibiting the antimicrobial preservative from adsorbing to contact lenses. It can be instilled to eyes with contact lenses on.

REFERENCES:
patent: 3911107 (1975-10-01), Krezanoski
patent: 4031209 (1977-06-01), Krezanoski
patent: 4470965 (1984-09-01), Wolf et al.
patent: 4571039 (1986-02-01), Poler
patent: 5318780 (1994-06-01), Viegas et al.
patent: 5347326 (1994-09-01), Volk
patent: 5558876 (1996-09-01), Desai et al.
patent: 5683709 (1997-11-01), Yamada et al.

Affiliated with

Also associated with

Rating

Ophthalmic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-824626